• Home >
  • Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry

Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry

Increasing Volume and Decreasing Value

09-Jan-2014  /  Research Code: NBAE-01-00-00-00  /  SKU: LS00111-GL-MR_16952  /  
Region: Global

Regular Price: USD 4,950.00

Special Price USD 4,455.00

10% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 4,455.00

PAY BY INVOICE

Be the first to review this product

This research service analyzes merger and acquisition trends in the global pharmaceutical and biotechnology industry, along with specific merger and acquisition deals in this industry. Analysis is based on the number of and the average value of these deals. Merger and acquisition trends are also observed and analyzed based on the geographic region and buyer type. This research study delves into the nature of cross-border deals and also explores various deal multiples such as enterprise value, percent stakes sought, and target stock premium analysis of target companies. The study concludes with 5 big predictions.

Table of Contents

Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry, Global Pharmaceutical and Biotechnology Industry: Mergers and Acquisitions TrendsPrefaceTitle, Research Team, and ContentsExecutive SummaryExecutive Summary and ImplicationsIntroductionIntroductionThe Key Rationale for M&AOverviewKey M&A StatisticsOverviewGeographic AnalysisOverviewCross-border Deal Analysis—Buyer’s Perspective for Asia-Pacific, Europe, and North AmericaOverviewSectorial Analysis—PharmaceuticalOverviewSectorial Analysis—BiotechnologyOverviewPercent Stake Sought and Target Stock Premium AnalysisOverviewConclusionThe 5 Big ConclusionsAppendixAdditional InformationThe Frost & Sullivan StoryThe Frost & Sullivan Story




Related Research

Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

Release Date : 12-Dec-17

Region : North America

A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

Release Date : 08-Dec-2015

Region : Asia Pacific

A Product and Pipeline Analysis of the Global Immunoglobulin Market

Release Date : 30-Sep-2015

Region : Global

Global Review of Intellectual Property (IP) Funds

Release Date : 29-Sep-2015

Region : Global

Insights for CFOs betting on Intellectual Property

Release Date : 29-Sep-2015

Region : Global

Strategic Overview of Patenting Activity in Pharma Sector of BRIC Countries

Release Date : 20-Sep-2015

Region : North America

Product and Pipeline Analysis of the Global Colorectal Cancer Market

Release Date : 09-Sep-2015

Region : North America

Vital Signs: Automation and Application Trends Drive Growth in Sample Preparation Markets

Release Date : 04-Sep-2015

Region : North America

Analysis of the Global Human Albumin Market and Product Pipeline

Release Date : 02-Sep-2015

Region : Asia Pacific

A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market

Release Date : 20-May-2015

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.